Works matching DE "SULINDAC"

Results: 147

Chemoprevention of carcinogenesis in familial tumors.

Published in:

International Journal of Clinical Oncology, 2004, v. 9, n. 4, p. 299, doi. 10.1007/s10147-004-0417-1

By:

Ishikawa, Hideki

Publication type:

Article

Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling.

Published in:

Magnetic Resonance, 2021, v. 2, n. 1, p. 355, doi. 10.5194/mr-2-355-2021

By:

Kamdem, Nestor;
Roske, Yvette;
Kovalskyy, Dmytro;
Platonov, Maxim O.;
Balinskyi, Oleksii;
Kreuchwig, Annika;
Saupe, Jörn;
Liang Fang;
Diehl, Anne;
Schmieder, Peter;
Krause, Gerd;
Rademann, Jörg;
Heinemann, Udo;
Birchmeier, Walter;
Oschkinat, Hartmut

Publication type:

Article

Effects of sulindac sulfide on proliferation and apoptosis of human breast cancer cell.

Published in:

Oncology Letters, 2018, v. 15, n. 5, p. 7981, doi. 10.3892/ol.2018.8331

By:

Sui, He-Huan;
Zhou, Yun-Jiang;
Wang, Hu;
Li, Li;
Cao, Min;
Huang, Jia-Jun

Publication type:

Article

Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer.

Published in:

Oncology Letters, 2018, v. 15, n. 1, p. 642, doi. 10.3892/ol.2017.7147

By:

Telang, Nitin

Publication type:

Article

Sulindac enhances cell proliferation in DMH-treated mouse colonic mucosa.

Published in:

Cell Proliferation, 1998, v. 31, n. 2, p. 59, doi. 10.1046/j.1365-2184.1998.00111.x

By:

Moorghen;
Orde;
Finney;
Appleton;
Watson;
Moorghen, M.

Publication type:

Article

Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms.

Published in:

Journal of Gastroenterology, 2009, v. 44, n. 9, p. 964, doi. 10.1007/s00535-009-0089-8

By:

Hayashi, Tsuyoshi;
Ishiwatari, Hirotoshi;
Ihara, Hideyuki;
Kawano, Yutaka;
Takada, Koichi;
Miyanishi, Koji;
Kobune, Masayoshi;
Takimoto, Rishu;
Sonoda, Tomoko;
Takayama, Tetsuji;
Kato, Junji;
Niitsu, Yoshiro

Publication type:

Article

Complete regression of colonic adenomas after treatment with sulindac in Gardner's syndrome: a 4-year follow-up.

Published in:

2001

By:

Okai, Takashi;
Yamaguchi, Yasushi;
Sakai, Junta;
Ohtsubo, Koushiro;
Mouri, Hisatsugu;
Sawabu, Norio;
Okai, T;
Yamaguchi, Y;
Sakai, J;
Ohtsubo, K;
Mouri, H;
Sawabu, N

Publication type:

journal article

Nutrient Availability Alters the Effect of Autophagy on Sulindac Sulfide-Induced Colon Cancer Cell Apoptosis.

Published in:

Gastroenterology Research & Practice, 2012, p. 1, doi. 10.1155/2012/897678

By:

Shiun-Kwei Chiou;
Hoa, Neil;
Lisheng Ge;
Jadus, Martin R.

Publication type:

Article

Drug-Induced Chronic Pancreatitis.

Published in:

2012

By:

Lee, Sarah C.;
Dalia, Samir M.

Publication type:

Case Study

Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients.

Published in:

Cancer Cell International, 2004, v. 4, p. 4, doi. 10.1186/1475-2867-4-4

By:

Frahm, Silke;
Kurtz, Andreas;
Kluwe, Lan;
Farassati, Faris;
Friedrich, Reinhad E.;
Mautner, Victor F.

Publication type:

Article

Syntheses of Platinum-Sulindac Complexes and Their Nanoparticles as Targeted Anticancer Drugs.

Published in:

Chemistry - A European Journal, 2016, v. 22, n. 6, p. 1926, doi. 10.1002/chem.201504915

By:

Hwu, Jih Ru;
Tsay, Shwu‐Chen;
Chuang, Kao Shu;
Kapoor, Mohit;
Lin, Jia Yu;
Yeh, Chen‐Sheng;
Su, Wu‐Chou;
Wu, Ping‐Ching;
Tsai, Tsung‐Lin;
Wang, Pei‐Wen;
Shieh, Dar‐Bin

Publication type:

Article

Sulindac Inhibits Growth of Rat Colon Carcinoma by Inducing Apoptosis.

Published in:

European Surgical Research, 2000, v. 32, n. 5, p. 305, doi. 10.1159/000008780

By:

Masunaga, R.;
Kohno, H.;
Kumar Dhar, D.;
Kotoh, T.;
Tachibana, M.;
Kubota, H.;
Nagasue, N.

Publication type:

Article

Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells.

Published in:

Journal of Experimental Therapeutics & Oncology, 2003, v. 3, n. 2, p. 83, doi. 10.1046/j.1359-4117.2003.01076.x

By:

Joe, Andrew K.;
Liu, Hui;
Xiao, Danhua;
Soh, Jae-Won;
Pinto, John T.;
Beer, David G.;
Piazza, Gary A.;
Joseph Thompson, W.;
Bernard Weinstein, I.

Publication type:

Article

Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).

Published in:

Carcinogenesis, 2013, v. 34, n. 9, p. 2090, doi. 10.1093/carcin/bgt170

By:

Li, Haonan;
Yang, Allison L.;
Chung, Yeon Tae;
Zhang, Wanying;
Liao, Jie;
Yang, Guang-Yu

Publication type:

Article

Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect.

Published in:

Carcinogenesis, 2010, v. 31, n. 11, p. 1982, doi. 10.1093/carcin/bgq149

By:

Liqun Huang;
Caihua Zhu;
Yu Sun;
Gang Xie;
Mackenzie, Gerardo G.;
Qiao, George;
Komninou, Despina;
Rigas, Basil

Publication type:

Article

Sulindac Reverses Aberrant Expression and Localization of β-Catenin in Papillary Thyroid Cancer Cells with the BRAFV600EMutation.

Published in:

Thyroid, 2010, v. 20, n. 6, p. 615, doi. 10.1089/thy.2009.0415

By:

Nancy L. Cho;
Chi-Iou Lin;
Edward E. Whang;
Adelaide M. Carothers;
Francis D. Moore;
Daniel T. Ruan

Publication type:

Article

Sulindac Compounds Facilitate the Cytotoxicity of β-Lapachone by Up-Regulation of NAD(P)H Quinone Oxidoreductase in Human Lung Cancer Cells.

Published in:

PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088122

By:

Kung, Hsiu-Ni;
Weng, Tsai-Yun;
Liu, Yu-Lin;
Lu, Kuo-Shyan;
Chau, Yat-Pang

Publication type:

Article

Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage.

Published in:

PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0039949

By:

Ayyanathan, Kasirajan;
Kesaraju, Shailaja;
Dawson-Scully, Ken;
Weissbach, Herbert

Publication type:

Article

Effect of Sulindac Sulfide on Metallohydrolases in the Human Colon Cancer Cell Line HT-29.

Published in:

PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0025725

By:

Guillen-Ahlers, Hector;
Tan, Jiangning;
Castellino, Francis J.;
Ploplis, Victoria A.

Publication type:

Article

Sulindac Sulfide Reverses Aberrant Self-Renewal of Progenitor Cells Induced by the AML-Associated Fusion Proteins PML/RARα and PLZF/RARα.

Published in:

PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022540

By:

Steinert, Gunnar;
Oancea, Claudia;
Roos, Jessica;
Hagemeyer, Heike;
Maier, Thorsten;
Ruthardt, Martin;
Puccetti, Elena

Publication type:

Article

Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress.

Published in:

PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005804

By:

Marchetti, Maria;
Resnick, Lionel;
Gamliel, Edna;
Kesaraju, Shailaja;
Weissbach, Herbert;
Binninger, David

Publication type:

Article

Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma.

Published in:

Cancer (0008543X), 2012, v. 118, n. 23, p. 5848, doi. 10.1002/cncr.27540

By:

Curiel-Lewandrowski, Clara;
Swetter, Susan M.;
Einspahr, Janine G.;
Hsu, Chiu-Hsieh;
Nagle, Ray;
Sagerman, Paul;
Tangrea, Joseph;
Parnes, Howard;
Alberts, David S.;
Chow, Hsiao-Hui

Publication type:

Article

Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke.

Published in:

FASEB Journal, 2004, v. 18, n. 13, p. 1559, doi. 10.1096/fj.04-1877fje

By:

Izzotti, Alberto;
Cartiglia, Cristina;
Longobardi, Mariagrazia;
Balansky, Roumen M.;
D'Agostini, Francesco;
Lubet, Ronald A.;
De Flora, Silvio

Publication type:

Article

Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.

Published in:

2015

By:

Xi Li;
Pathi, Satya S.;
Safe, Stephen;
Li, Xi

Publication type:

journal article

Hydrophobically modified alginate for extended release of pharmaceuticals.

Published in:

Polymers for Advanced Technologies, 2018, v. 29, n. 1, p. 198, doi. 10.1002/pat.4103

By:

Choudhary, Soumitra;
Reck, Jason M.;
Carr, Amanda J.;
Bhatia, Surita R.

Publication type:

Article

Sulindac and vitamin D3 synergically inhibit proliferation of MCF‐7 breast cancer cell through AMPK/Akt/β‐catenin axis in vitro.

Published in:

Cell Biochemistry & Function, 2021, v. 39, n. 8, p. 991, doi. 10.1002/cbf.3668

By:

Poursoltani, Faezeh;
Nejati, Vahid;
Pazhang, Yaghub;
Rezaie, Jafar

Publication type:

Article

Aseptic meningitis associated with chronic sulindac use for osteoarthritis: a case report.

Published in:

Rheumatology International, 2008, v. 28, n. 4, p. 391, doi. 10.1007/s00296-007-0439-x

By:

Callen, Erin C.;
Church, Chelsea O.;
Patel, Manish;
Sikes, Tiffany L.

Publication type:

Article

Untitled.

Published in:: 2016
Publication type:: Abstract

Chemopreventive Role of Sulindac Sulfone on 4-nitroquinoline 1-oxide-induced Head and Neck Squamous Cell Carcinogenesis in Rats.

Published in:

World Journal of Dentistry, 2024, v. 15, n. 2, p. 141, doi. 10.5005/jp-journals-10015-2370

By:

Karuppiah, Nivethitha;
Sukumaran, Gheena;
Ramani, Pratibha;
Ramasubramanian, Abilasha

Publication type:

Article

Sulindac loaded alginate beads for a mucoprotective and controlled drug release.

Published in:

Journal of Microencapsulation, 2007, v. 24, n. 4, p. 371, doi. 10.1080/02652040701298153

By:

Yegin, Betül Arıca;
Moulari, Brice;
Tugba Durlu-Kandilci, N.;
Korkusuz, Petek;
Pellequer, Yann;
Lamprecht, Alf

Publication type:

Article

Clinical Outcome of Tamoxifen and Sulindac for Desmoid Tumors in Adults: A Phase II Single Institution Experience.

Published in:

Middle East Journal of Cancer, 2019, v. 10, n. 2, p. 125

By:

Anter, Abeer Hussien;
Abdel-Latif, Rasha Mohamed

Publication type:

Article

Sulindac and Erlotinib for Familial Adenomatous Polyposis.

Published in:

2016

By:

Matuchansky, Claude

Publication type:

commentary

Sulindac and Erlotinib for Familial Adenomatous Polyposis--Reply.

Published in:

2016

By:

Samadder, N. Jewel;
Neklason, Deborah W.;
Burt, Randall W.

Publication type:

Letter

Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.

Published in:

2016

By:

Samadder, N. Jewel;
Neklason, Deborah W.;
Boucher, Kenneth M.;
Byrne, Kathryn R.;
Kanth, Priyanka;
Samowitz, Wade;
Jones, David;
Tavtigian, Sean V.;
Done, Michelle W.;
Berry, Therese;
Jasperson, Kory;
Pappas, Lisa;
Smith, Laurel;
Sample, Danielle;
Davis, Rian;
Topham, Matthew K.;
Lynch, Patrick;
Strait, Elena;
McKinnon, Wendy;
Burt, Randall W.

Publication type:

journal article

Sulindac-Associated Choledocholithiasis.

Published in:

2001

By:

Eda, Akashi;
Yanaka, Ichiro;
Tamada, Kiichi;
Wada, Shinichi;
Tomiyama, Takeshi;
Sugano, Kentaro

Publication type:

Letter

Chemoprevention Adds Up.

Published in:

American Journal of Gastroenterology (Springer Nature), 2001, v. 96, n. 2, p. 278, doi. 10.1016/S0002-9270(00)02383-2

By:

Roy, H.;
Thompson, Jon S.

Publication type:

Article

Drug-Associated Acute Pancreatitis: Twenty-one Years of Spontaneous Reporting in the Netherlands.

Published in:

American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 9, p. 2417, doi. 10.1111/j.1572-0241.1999.01367.x

By:

Eland, I. A.;
Van Puijenbroek, E. P.;
Sturkenboom, M. J. C. M.;
Wilson, J. H. P.;
Stricker, B. H. Ch.

Publication type:

Article

Drug-Associated Cholelithiasis: A Case of Sulindac Stone Formation and the Incorporation of Sulindac Metabolites Into the Gallstones.

Published in:

American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 8, p. 2285, doi. 10.1111/j.1572-0241.1999.01315.x

By:

Tokumine, Fumio;
Sunagawa, Toru;
Shiohira, Yoshiki;
Nakamoto, Tsuguo;
Miyazato, Fujihiko;
Muto, Yoshihiro

Publication type:

Article

Rectal Cancer After Sulindac Therapy for a Sporadic Adenomatous Colonic Polyp.

Published in:

American Journal of Gastroenterology (Springer Nature), 1998, v. 93, n. 11, p. 2261, doi. 10.1111/j.1572-0241.1998.00630.x

By:

Matsuhashi, N.;
Nakajima, A.;
Shinohara, K.;
Oka, T.;
Yazaki, Y.

Publication type:

Article

Regression of an Aggressive Abdominal Desmoid Tumor in a Patient with Familial Adenomatous Polyposis by Hyperthermoradiotherapy.

Published in:

American Journal of Gastroenterology (Springer Nature), 1997, v. 92, n. 1, p. 156

By:

Oohata, Yoshihiro;
Mibu, Ryuichi;
Uehara, Satoru;
Iida, Mitsuo;
Ishikawa, Mikimasa;
Sakai, Masashi;
Tanaka, Masao

Publication type:

Article

SULINDAC-ASSOCIATED ULCERATIVE POUCHITIS IN FAMILIAL ADENOMATOUS POLYPOSIS.

Published in:

American Journal of Gastroenterology (Springer Nature), 1996, v. 91, n. 11, p. 2431

By:

Bertoni, Giorgio;
Sassatelli, Romano;
Bedogni, Giuliano;
Nigrisoli, Evandro

Publication type:

Article

Disappearance of Duodenal Polyps in Gardner's Syndrome with Sulindac Therapy.

Published in:

American Journal of Gastroenterology (Springer Nature), 1993, v. 88, n. 1, p. 93

By:

Parker, Allan L.;
Kadakia, Shailesh C.;
Maccini, D. M.;
Cassaday, Michael A.;
Angueira, Carlos K.

Publication type:

Article

Sulindac-Induced Severe Hepatitis.

Published in:

1988

By:

Daniele, Bruno;
Pignata, Sandro;
D'Agostino, Luciano;
Vecchione, Raffaella;
Mazzacca, Gabriele

Publication type:

Letter

Tri- and diorganotin(IV) derivatives of non-steroidal anti-inflammatory drug sulindac: Characterization, electronic structures (DFT), DNA binding and plasmid cleavage studies.

Published in:

Applied Organometallic Chemistry, 2017, v. 31, n. 8, p. n/a, doi. 10.1002/aoc.3661

By:

Kumari, Ranjana;
Nath, Mala

Publication type:

Article

A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 79, doi. 10.1007/s00280-006-0240-7

By:

O'Connor, R.;
O'Leary, M.;
Ballot, J.;
Collins, C. D.;
Kinsella, P.;
Mager, D. E.;
Arnold, R. D.;
O'Driscoll, L.;
Larkin, A.;
Kennedy, S.;
Fennelly, D.;
Clynes, M.;
Crown, J.

Publication type:

Article

Shifting the cut of APP.

Published in:

Nature Reviews Drug Discovery, 2004, v. 3, n. 1, p. 14, doi. 10.1038/nrd1296

By:

Ellis, Clare

Publication type:

Article

Ornithine Decarboxylase-1 Polymorphism, Chemoprevention With Eflornithine and Sulindac, and Outcomes Among Colorectal Adenoma Patients.

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 19, p. 1513, doi. 10.1093/jnci/djq325

By:

Zell, Jason A.;
McLaren, Christine E.;
Wen-Pin Chen;
Thompson, Patricia A.;
Gerner, Eugene W.;
Meyskens, Frank L.

Publication type:

Article

Drugs To Prevent Colon Cancer Show Promise, But Hurdles Remain for Chemoprevention.

Published in:

JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 11, p. 764, doi. 10.1093/jnci/djn187

By:

Tuma, Rabiya

Publication type:

Article

Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activity.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 921, doi. 10.1080/14756366.2020.1746783

By:

Bhat, Mashooq A.;
Al-Omar, Mohamed A.;
Alsaif, Nawaf A.;
Almehizia, Abdulrahman A.;
Naglah, Ahmed M.;
Razak, Suhail;
Khan, Azmat Ali;
Ashraf, Naeem Mahmood

Publication type:

Article

Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers.

Published in:

BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/4189678

By:

Tang, Yong-Jun;
Hu, Kai;
Huang, Wei-Hua;
Wang, Chong-Zhi;
Liu, Zhi;
Chen, Yao;
Ouyang, Dong-Sheng;
Tan, Zhi-Rong;
Zhou, Hong-Hao;
Yuan, Chun-Su

Publication type:

Article